Showing results (1501-1510 of 2,309) with videos related to

Sort By:
Pageof 231
Journal of the International AIDS Society|November 8, 2014
The impact of SASA!, a community mobilization intervention, on reported HIV-related risk behaviours and relationship dynamics in Kampala, UgandaNambusi Kyegombe, Tanya Abramsky, Karen M Devries, et al.
Glia|March 10, 2001
Neurotrophic and migratory properties of an olfactory ensheathing cell lineA V Boruch, J J Conners, M Pipitone, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2001
Social stress exacerbates stroke outcome by suppressing Bcl-2 expressionA C DeVries, H D Joh, O Bernard, et al.
Organic & Biomolecular Chemistry|June 22, 2013
Chemical synthesis of a masked analogue of the fish antifreeze potentiating protein (AFPP)Sung-Hyun Yang, Joanna M Wojnar, Paul W R Harris, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1985
Influence of educational and sociocultural factors on hypertension careJ Ménard, P Degoulet, G Chatellier, et al.
PLOS Global Public Health|March 18, 2024
Experiences of teachers and students on school closures and its consequences during the COVID-19 pandemic in Nyarugusu refugee camp, TanzaniaElizabeth H Shayo, Godfrey Mubyazi, Vivien Barongo, et al.
Plos One|August 24, 2023
Metabolic responses and performance of Holstein × Gyr heifers grazing Brachiaria decumbens supplemented with varied crude protein levelsMarcelo Messias Duarte Castro, Trevor James DeVries, Andreia Ferreira Machado, et al.
Human Pathology|April 19, 2011
Genomic alterations and phenotype of large compared to small high-grade ductal carcinoma in situE Shelley Hwang, Aseem Lal, Yunn-Yi Chen, et al.
BMC Public Health|April 22, 2022
Paper: violence, abuse and exploitation among trafficked women and girls: a mixed-methods study in Nigeria and UgandaLigia Kiss, David Fotheringhame, Nambusi Kyegombe, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trialsBernard Zinman, J Hans DeVries, Bruce Bode, et al.
Pageof 231